Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey - Aix-Marseille Université Access content directly
Journal Articles Bone Marrow Transplantation Year : 2020

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Leopold Sellner
  • Function : Author
Johannes Schetelig
Linda Koster
  • Function : Author
Goda Choi
  • Function : Author
Dietrich Beelen
  • Function : Author
Fabrizio Carnevale Schianca
  • Function : Author
Jakob Passweg
  • Function : Author
Urs Schanz
  • Function : Author
Emmanuel Gyan
Federica Sora
  • Function : Author
Nicolaus Kröger
Gerald. Wulf
  • Function : Author
Gwendolyn van Gorkom
  • Function : Author
Jiri Mayer
  • Function : Author
Corentin Orvain
Jean Henri Bourhis
  • Function : Author
Pavel Jindra
  • Function : Author
Victoria Potter
  • Function : Author
Francesco Zallio
  • Function : Author
Elisabeth Vandenberghe
  • Function : Author
Stephen Robinson
  • Function : Author
Patrick Hayden
  • Function : Author
Silvia Montoto
  • Function : Author
Peter Dreger

Domains

Immunology
Fichier principal
Vignette du fichier
41409_2020_Article_946.pdf (535.14 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Licence : CC BY - Attribution

Dates and versions

hal-03152802 , version 1 (19-06-2023)

Licence

Attribution

Identifiers

Cite

Leopold Sellner, Johannes Schetelig, Linda Koster, Goda Choi, Didier Blaise, et al.. Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone Marrow Transplantation, 2020, 55 (12), pp.2335-2338. ⟨10.1038/s41409-020-0946-x⟩. ⟨hal-03152802⟩
19 View
2 Download

Altmetric

Share

Gmail Facebook X LinkedIn More